Modulating signaling pathways in hypertrophy and heart failure by gene transfer

Fawzia Huq, Federica Del Monte, Roger J. Hajjar

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Gene transfer to the heart is a novel concept that holds great promise both as a therapeutic and an experimental tool. With the advent of improved vector technology and new insights into the pathophysiology of heart failure, it is now possible to target specific intracellular signaling pathways by adenoviral gene transfer. By over or under expressing a specific protein, complex pathways can be probed specifically, and the role of various molecular targets within crucial intracellular pathways can be more precisely defined. This review highlights recent advances made in the field of myocardial gene transfer, with an emphasis on how manipulation of signal transduction pathways by adenoviral gene transfer has been used to elucidate the pathophysiology underlying abnormal cardiac phenotypes that lead to cardiac failure, such as hypertrophy, contractile dysfunction, and apoptosis.

Original languageEnglish
Pages (from-to)S389-S400
JournalJournal of Cardiac Failure
Issue number6 SUPPL.
StatePublished - Dec 2002
Externally publishedYes


  • Gene transfer
  • Heart failure
  • Hypertrophy
  • Signaling pathways


Dive into the research topics of 'Modulating signaling pathways in hypertrophy and heart failure by gene transfer'. Together they form a unique fingerprint.

Cite this